Stock Analysis·← Pickers

TLRY

Tilray Brands, Inc.

Tilray Brands, Inc. (TLRY) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 37.0, with 0/3 trend checks passing.

Price
$4.38
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
37.0
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

TLRY with MA50 and MA200

21.0016.8312.658.484.3107/3110/2401/2204/1707/15
TLRY2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$5.03-12.89% vs price
MA200
$8.51-48.56% vs price
RSI (14)
37.0Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for TLRY

Tilray Brands, Inc. (TLRY) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $4.38, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 12.9% and below the 200-day moving average by 48.6%.

Momentum and stretch context

TLRY currently has an RSI reading of 37.0, which leans a little softer than neutral. That does not automatically make the chart bearish, but it does suggest momentum is not especially strong right now.

What traders may watch next

For traders reviewing TLRY next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Tilray Brands, Inc.

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Irwin David Simon
Employees
2,842
Market cap
$525.6M
Beta
1.90
52-week range
$4.20 – $23.20
Dividend
No
Exchange
NASDAQ
Country
CA
IPO date
19 Jul 2018
ISIN
US88688T2096
CUSIP
88688T209
Website
tilray.com
Company profile data from Financial Modeling Prep. TLRY listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about TLRY

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.